Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: Tokyo
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Kaken Pharmaceutical Co Ltd

+ Add to Watchlist

4521:JP

1,634 JPY 7 0.43%

As of 02:00:00 ET on 05/24/2013.

Company Profile for Kaken Pharmaceutical Co Ltd (4521)

KAKEN PHARMACEUTICAL CO., LTD. develops, produces, and sells pharmaceuticals and agrochemicals. The Company's products are mainly for nervous, circulatory, respiratory, digestive, urinary, sensory, and metabolic systems. Kaken Pharmaceutical also manufactures antibiotics and feed additives. The Company as well manufactures air purifiers and operates real estate business.

Contact Information

Kaken Pharmaceutical Co Ltd

2-28-8 Honkomagome
Bunkyo-ku
Tokyo, 113-8650
Japan
Phone: 81-3-5977-5001
Fax: 81-3-5977-5131

Key Executives for Kaken Pharmaceutical Co Ltd (4521)

Shiro InuiChairmanTetsuo OhnumaPresident
Susumu KojimaExecutive Managing DirectorHirokazu KonishiExecutive Managing Director
Yoshihiro IedaExecutive Managing DirectorNoboru ShibataExecutive Managing Director
Masao IshidaExecutive DirectorTakao EndoExecutive Director
Toshio NakajimaExecutive OfficerSohachi NakauchiExecutive Officer
Hitoshi OsadaExecutive OfficerKatsumi NogimoriExecutive Officer
Iwao AokiExecutive OfficerKenichi NakamuraExecutive Officer
Masaaki YokoyamaExecutive OfficerAkira TakahashiExecutive Officer
Toshiyuki TakahashiExecutive Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil